KALA
KALA BIO, Inc.
Price Chart
Latest Quote
$2.55
-0.45 (-15.00%)
Current Price
| Previous Close | $3.00 |
| Open | $2.96 |
| Day High | $3.01 |
| Day Low | $2.55 |
| Volume | 51,775 |
Stock Information
| Shares Outstanding | 18.59M |
| Cash Equivalents | $8.76M |
| Net Income | $-19.65M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $47.40M |
| EPS (TTM) | $-102.01 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $38.64M |
| Income | $-19.65M |
| Book/sh | $0.58 |
| Cash/sh | $0.47 |
| Employees | 6 |
Financial Ratios
| Quick Ratio | 5.68 |
| Current Ratio | 7.91 |
Returns & Margins
| ROA | -69.27% |
| ROE | -238.68% |
Ownership
| Insider Ownership | 1.30% |
| Institutional Ownership | 0.64% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.38 |
| P/B | 4.40 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $2.61 |
| SMA50 | $4.21 |
| SMA200 | $85.38 |
| RSI | 54.75 |
| ATR | 0.4341 |
| Shares Float | 18.59M |
| Short Float | 0.35% |
| Short Ratio | 0.70 |
| Volatility | -2.41 |
| Rel Volume | 0.35 |
Performance History
| Week | -10.37% |
| Month | +17.51% |
| Quarter | -76.17% |
| 6 Months | -91.31% |
| YTD | -91.79% |
| Year | -98.73% |
| 3 Years | -99.66% |
| 5 Years | -99.98% |
| 10 Years | -99.99% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $2.55 | 52,100 |
| 2026-06-24 | $3.00 | 71,100 |
| 2026-06-23 | $3.12 | 67,600 |
| 2026-06-22 | $3.54 | 142,000 |
| 2026-06-18 | $3.61 | 959,200 |
| 2026-06-17 | $2.85 | 143,100 |
| 2026-06-16 | $3.14 | 175,200 |
| 2026-06-15 | $2.64 | 90,200 |
| 2026-06-12 | $2.63 | 198,200 |
| 2026-06-11 | $2.47 | 72,800 |
| 2026-06-10 | $2.39 | 74,200 |
| 2026-06-09 | $2.35 | 84,300 |
| 2026-06-08 | $2.29 | 232,900 |
| 2026-06-05 | $2.06 | 127,600 |
| 2026-06-04 | $2.23 | 100,000 |
| 2026-06-03 | $2.24 | 57,800 |
| 2026-06-02 | $2.39 | 127,100 |
| 2026-06-01 | $2.20 | 102,500 |
| 2026-05-29 | $2.23 | 60,700 |
| 2026-05-28 | $2.29 | 60,200 |
| 2026-05-27 | $2.33 | 46,000 |
| 2026-05-26 | $2.17 | 134,000 |
About KALA BIO, Inc.
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment. Its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-concept validation environment, as well as the mesenchymal stem cell secretome (MSC-S) and persistent corneal epithelial defects (PCED) research for agentic workflows on trial data. The company serves biotechnology and pharmaceutical companies. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.
đ° Latest News
BC-Most Active Stocks
Associated Press Finance âĸ 2026-03-11T14:30:34ZTop Midday Gainers
MT Newswires âĸ 2025-12-01T18:32:48ZKALA BIO: Q3 Earnings Snapshot
Associated Press Finance âĸ 2025-11-19T23:11:36ZKALA Stock Crashes 88% in a Month Following Eye Disorder Study Failure
Zacks âĸ 2025-10-08T15:18:00Z
Top Midday Decliners
MT Newswires âĸ 2025-09-30T18:22:51ZKALA BIO, Inc.'s (NASDAQ:KALA) market cap surged US$28m last week, retail investors who have a lot riding on the company were rewarded
Simply Wall St. âĸ 2025-09-05T10:20:19Z
Wall Street Analysts Believe KALA BIO (KALA) Could Rally 74.73%: Here's is How to Trade
Zacks âĸ 2025-08-13T13:55:02Z
KALA BIO: Q2 Earnings Snapshot
Associated Press Finance âĸ 2025-08-08T12:08:11ZZacks.com featured highlights include KALA, Graham, Arq and Hawkins
Zacks âĸ 2025-07-28T12:23:00Z
Analyst Coverage Sparks Interest in These 4 Stocks Amid Volatility
Zacks âĸ 2025-07-25T15:55:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $3,892,000 |
| Operating Revenue | $0 | $0 | $0 | $3,892,000 |
| Reconciled Cost Of Revenue | - | - | $0 | $2,560,000 |
| Cost Of Revenue | - | - | $0 | $2,560,000 |
| Expenses | ||||
| Interest Expense | $3,276,000 | $5,783,000 | $5,814,000 | $7,266,000 |
| Total Expenses | $39,032,000 | $34,235,000 | $34,328,000 | $85,248,000 |
| Other Income Expense | $14,188,000 | $-549,000 | $-4,768,000 | $43,136,000 |
| Other Non Operating Income Expenses | $5,147,000 | - | $-4,258,000 | $-926,000 |
| Net Non Operating Interest Income Expense | $-2,136,000 | $-3,727,000 | $-3,103,000 | $-6,602,000 |
| Interest Expense Non Operating | $3,276,000 | $5,783,000 | $5,814,000 | $7,266,000 |
| Operating Expense | $39,032,000 | $34,235,000 | $34,328,000 | $82,688,000 |
| Other Operating Expenses | $-3,377,000 | $-6,199,000 | $-4,825,000 | - |
| General And Administrative Expense | $23,629,000 | $18,340,000 | $20,567,000 | $65,035,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-26,980,000 | $-38,511,000 | $-42,199,000 | $-44,822,000 |
| Net Interest Income | $-2,136,000 | $-3,727,000 | $-3,103,000 | $-6,602,000 |
| Interest Income | $1,140,000 | $2,056,000 | $2,711,000 | $664,000 |
| Normalized Income | $-36,021,000 | $-37,962,000 | $-41,689,000 | $-88,884,000 |
| Net Income From Continuing And Discontinued Operation | $-26,980,000 | $-38,511,000 | $-42,199,000 | $-44,822,000 |
| Total Operating Income As Reported | $-39,161,000 | $-40,983,000 | $-39,663,000 | $-81,706,000 |
| Net Income Common Stockholders | $-26,980,000 | $-38,511,000 | $-42,199,000 | $-44,822,000 |
| Net Income | $-26,980,000 | $-38,511,000 | $-42,199,000 | $-44,822,000 |
| Net Income Including Noncontrolling Interests | $-26,980,000 | $-38,511,000 | $-42,199,000 | $-44,822,000 |
| Net Income Continuous Operations | $-26,980,000 | $-38,511,000 | $-42,199,000 | $-44,822,000 |
| Pretax Income | $-26,980,000 | $-38,511,000 | $-42,199,000 | $-44,822,000 |
| Special Income Charges | $9,041,000 | $-549,000 | $-510,000 | $44,062,000 |
| Interest Income Non Operating | $1,140,000 | $2,056,000 | $2,711,000 | $664,000 |
| Operating Income | $-39,032,000 | $-34,235,000 | $-34,328,000 | $-81,356,000 |
| Gross Profit | - | - | $0 | $1,332,000 |
| Per Share | ||||
| Diluted EPS | $-165.50 | $-507.50 | $-867.50 | $-1474.00 |
| Basic EPS | $-165.50 | $-507.50 | $-867.50 | $-1474.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-32,428,000 | $-31,920,000 | $-35,572,000 | $-81,081,000 |
| Total Unusual Items | $9,041,000 | $-549,000 | $-510,000 | $44,062,000 |
| Total Unusual Items Excluding Goodwill | $9,041,000 | $-549,000 | $-510,000 | $44,062,000 |
| Reconciled Depreciation | $317,000 | $259,000 | $303,000 | $537,000 |
| EBITDA (Bullshit earnings) | $-23,387,000 | $-32,469,000 | $-36,082,000 | $-37,019,000 |
| EBIT | $-23,704,000 | $-32,728,000 | $-36,385,000 | $-37,556,000 |
| Diluted Average Shares | $162,965 | $75,920 | $48,640 | $30,412 |
| Basic Average Shares | $162,965 | $75,920 | $48,640 | $30,412 |
| Diluted NI Availto Com Stockholders | $-26,980,000 | $-38,511,000 | $-42,199,000 | $-44,822,000 |
| Other Special Charges | $-5,793,000 | - | - | $2,583,000 |
| Impairment Of Capital Assets | $1,411,000 | $0 | - | - |
| Restructuring And Mergern Acquisition | $-4,659,000 | $549,000 | $510,000 | $350,000 |
| Research And Development | $18,780,000 | $22,094,000 | $18,586,000 | $17,653,000 |
| Selling General And Administration | $23,629,000 | $18,340,000 | $20,567,000 | $65,035,000 |
| Other Gand A | $23,629,000 | $18,340,000 | $20,567,000 | $65,035,000 |
| Gain On Sale Of Business | - | - | $0 | $46,995,000 |
Fetched: 2026-06-24
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $6,996,000 | $12,332,000 | $7,504,000 | $18,974,000 |
| Total Assets | $9,490,000 | $55,483,000 | $55,949,000 | $86,820,000 |
| Total Non Current Assets | $0 | $2,686,000 | $3,079,000 | $878,000 |
| Current Assets | $9,490,000 | $52,797,000 | $52,870,000 | $85,942,000 |
| Other Current Assets | $1,933,000 | $1,616,000 | $1,975,000 | $657,000 |
| Cash Cash Equivalents And Short Term Investments | $7,557,000 | $51,181,000 | $50,895,000 | $70,495,000 |
| Cash And Cash Equivalents | $7,557,000 | $51,181,000 | $50,895,000 | $70,495,000 |
| Other Non Current Assets | - | $246,000 | $301,000 | $462,000 |
| Assets Held For Sale Current | - | - | $0 | $7,595,000 |
| Prepaid Assets | - | - | $555,000 | $698,000 |
| Receivables | - | - | $236,000 | $6,497,000 |
| Other Receivables | - | - | $119,000 | $908,000 |
| Accounts Receivable | - | - | $117,000 | $195,000 |
| Restricted Cash | - | - | - | $0 |
| Inventory | - | - | - | $0 |
| Debt | ||||
| Total Debt | $0 | $32,252,000 | $36,323,000 | $42,950,000 |
| Long Term Debt And Capital Lease Obligation | $0 | $21,536,000 | $35,989,000 | $37,937,000 |
| Long Term Debt | - | $20,102,000 | $34,190,000 | $37,937,000 |
| Current Debt And Capital Lease Obligation | - | $10,716,000 | $334,000 | $5,013,000 |
| Current Debt | - | $10,336,000 | - | $5,000,000 |
| Other Current Borrowings | - | $10,336,000 | - | $5,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,494,000 | $43,151,000 | $48,445,000 | $67,846,000 |
| Total Non Current Liabilities Net Minority Interest | $0 | $26,195,000 | $40,099,000 | $42,161,000 |
| Current Liabilities | $2,494,000 | $16,956,000 | $8,346,000 | $25,685,000 |
| Current Deferred Liabilities | $0 | $637,000 | $1,075,000 | $4,784,000 |
| Payables And Accrued Expenses | $2,314,000 | $3,213,000 | $4,321,000 | $8,408,000 |
| Payables | $986,000 | $628,000 | $919,000 | $2,832,000 |
| Accounts Payable | $986,000 | $628,000 | $919,000 | $2,832,000 |
| Other Non Current Liabilities | - | $4,659,000 | $4,110,000 | $4,224,000 |
| Non Current Deferred Liabilities | - | - | - | $0 |
| Other Current Liabilities | - | - | - | $4,146,000 |
| Equity | ||||
| Common Stock Equity | $6,995,000 | $12,332,000 | $7,504,000 | $18,974,000 |
| Preferred Stock Equity | $1,000 | - | - | - |
| Total Equity Gross Minority Interest | $6,996,000 | $12,332,000 | $7,504,000 | $18,974,000 |
| Stockholders Equity | $6,996,000 | $12,332,000 | $7,504,000 | $18,974,000 |
| Retained Earnings | $-694,900,000 | $-667,920,000 | $-629,409,000 | $-587,210,000 |
| Gains Losses Not Affecting Retained Earnings | - | - | $0 | $0 |
| Other | ||||
| Ordinary Shares Number | $556,994 | $121,823 | $55,187 | $34,139 |
| Share Issued | $556,994 | $121,823 | $55,187 | $34,139 |
| Tangible Book Value | $6,995,000 | $12,332,000 | $7,504,000 | $18,974,000 |
| Invested Capital | $6,995,000 | $42,770,000 | $41,694,000 | $61,911,000 |
| Working Capital | $6,996,000 | $35,841,000 | $44,524,000 | $60,257,000 |
| Capital Lease Obligations | $0 | $1,814,000 | $2,133,000 | $13,000 |
| Total Capitalization | $6,996,000 | $32,434,000 | $41,694,000 | $56,911,000 |
| Additional Paid In Capital | $701,867,000 | $680,246,000 | $636,910,000 | $606,182,000 |
| Capital Stock | $29,000 | $6,000 | $3,000 | $2,000 |
| Common Stock | $28,000 | $6,000 | $3,000 | $2,000 |
| Preferred Stock | $1,000 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $0 | $1,434,000 | $1,799,000 | $0 |
| Current Deferred Revenue | $0 | $637,000 | $1,075,000 | $4,189,000 |
| Current Capital Lease Obligation | $0 | $380,000 | $334,000 | $13,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $180,000 | $2,390,000 | $2,616,000 | $3,334,000 |
| Current Accrued Expenses | $1,328,000 | $2,585,000 | $3,402,000 | $5,576,000 |
| Net PPE | $0 | $2,440,000 | $2,778,000 | $416,000 |
| Accumulated Depreciation | $-869,000 | $-1,314,000 | $-1,110,000 | $-1,224,000 |
| Gross PPE | $869,000 | $3,754,000 | $3,888,000 | $1,640,000 |
| Machinery Furniture Equipment | $869,000 | $869,000 | $869,000 | $1,233,000 |
| Buildings And Improvements | $0 | $1,691,000 | $2,025,000 | $16,000 |
| Properties | $0 | $0 | $0 | $0 |
| Construction In Progress | - | $0 | $100,000 | $0 |
| Other Properties | - | $1,194,000 | $894,000 | $391,000 |
| Duefrom Related Parties Current | - | - | $0 | $5,394,000 |
| Current Provisions | - | - | - | $807,000 |
| Leases | - | - | - | - |
| Other Short Term Investments | - | - | - | - |
Fetched: 2026-06-24
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-32,006,000 | $-29,590,000 | $-28,537,000 | $-79,221,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-31,991,000 | $-29,382,000 | $-27,927,000 | $-78,908,000 |
| Cash Flow From Continuing Operating Activities | $-31,991,000 | $-29,382,000 | $-27,927,000 | $-78,908,000 |
| Operating Gains Losses | $-5,244,000 | - | - | $-44,412,000 |
| Investing Activities | ||||
| Capital Expenditure | $-15,000 | $-208,000 | $-610,000 | $-313,000 |
| Investing Cash Flow | $-15,000 | $-208,000 | $-429,000 | $62,717,000 |
| Cash Flow From Continuing Investing Activities | $-15,000 | $-208,000 | $-429,000 | $62,717,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $10,934,000 | $34,963,000 | $20,501,000 | $31,796,000 |
| Financing Cash Flow | $-11,618,000 | $29,876,000 | $8,506,000 | $-7,942,000 |
| Cash Flow From Continuing Financing Activities | $-11,618,000 | $29,876,000 | $8,506,000 | $-7,942,000 |
| Net Other Financing Charges | $-120,000 | $-119,000 | $-2,041,000 | - |
| Net Preferred Stock Issuance | $1,800,000 | $8,538,000 | $1,965,000 | $0 |
| Preferred Stock Issuance | $1,800,000 | $8,538,000 | $1,965,000 | $0 |
| Net Common Stock Issuance | $9,134,000 | $26,425,000 | $18,536,000 | $31,796,000 |
| Common Stock Issuance | $9,134,000 | $26,425,000 | $18,536,000 | $31,796,000 |
| Other | ||||
| Repayment Of Debt | $-22,505,000 | $-5,045,000 | $-10,000,000 | $-40,039,000 |
| Interest Paid Supplemental Data | $2,701,000 | $4,610,000 | $4,620,000 | $5,958,000 |
| End Cash Position | $7,557,000 | $51,181,000 | $50,895,000 | $70,745,000 |
| Beginning Cash Position | $51,181,000 | $50,895,000 | $70,745,000 | $94,878,000 |
| Changes In Cash | $-43,624,000 | $286,000 | $-19,850,000 | $-24,133,000 |
| Proceeds From Stock Option Exercised | $73,000 | $77,000 | $46,000 | $301,000 |
| Net Issuance Payments Of Debt | $-22,505,000 | $-5,045,000 | $-10,000,000 | $-40,039,000 |
| Net Long Term Debt Issuance | $-22,505,000 | $-5,045,000 | $-10,000,000 | $-40,039,000 |
| Long Term Debt Payments | $-22,505,000 | $-5,045,000 | $-10,000,000 | $-40,039,000 |
| Net PPE Purchase And Sale | $-15,000 | $-208,000 | $-563,000 | $-199,000 |
| Purchase Of PPE | $-15,000 | $-208,000 | $-610,000 | $-313,000 |
| Change In Working Capital | $-5,521,000 | $-1,779,000 | $8,895,000 | $491,000 |
| Change In Other Current Liabilities | $-1,813,000 | $-319,000 | $-13,000 | $-344,000 |
| Change In Other Current Assets | $144,000 | $0 | $-144,000 | $0 |
| Change In Payables And Accrued Expense | $-3,535,000 | $-1,819,000 | $-4,326,000 | $-14,002,000 |
| Change In Accrued Expense | $-3,893,000 | $-1,528,000 | $-2,422,000 | $-11,926,000 |
| Change In Payable | $358,000 | $-291,000 | $-1,904,000 | $-2,076,000 |
| Change In Account Payable | $358,000 | $-291,000 | $-1,904,000 | $-2,076,000 |
| Change In Prepaid Assets | $-317,000 | $359,000 | $5,834,000 | $-2,009,000 |
| Other Non Cash Items | $-2,969,000 | $2,260,000 | $-2,389,000 | $2,290,000 |
| Stock Based Compensation | $6,995,000 | $8,389,000 | $7,463,000 | $7,008,000 |
| Asset Impairment Charge | $1,411,000 | $0 | - | - |
| Depreciation Amortization Depletion | $317,000 | $259,000 | $303,000 | $537,000 |
| Depreciation And Amortization | $317,000 | $259,000 | $303,000 | $537,000 |
| Gain Loss On Sale Of PPE | $549,000 | $0 | - | - |
| Net Income From Continuing Operations | $-26,980,000 | $-38,511,000 | $-42,199,000 | $-44,822,000 |
| Net Investment Purchase And Sale | - | $0 | $134,000 | $8,000 |
| Sale Of Investment | - | $0 | $10,000,000 | $5,000,000 |
| Purchase Of Investment | - | $0 | $-9,866,000 | $-4,992,000 |
| Sale Of PPE | - | $0 | $47,000 | $114,000 |
| Change In Inventory | - | $0 | $7,544,000 | $1,708,000 |
| Net Business Purchase And Sale | - | - | $0 | $62,908,000 |
| Sale Of Business | - | - | $0 | $62,908,000 |
| Change In Receivables | - | - | $78,000 | $15,138,000 |
| Changes In Account Receivables | - | - | $78,000 | $15,138,000 |
| Gain Loss On Sale Of Business | - | - | $0 | $-46,995,000 |
| Issuance Of Debt | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
| Net Intangibles Purchase And Sale | - | - | - | $0 |
| Purchase Of Intangibles | - | - | - | $0 |
| Purchase Of Business | - | - | - | - |
| Amortization Of Securities | - | - | - | - |
Fetched: 2026-06-24